Featured News

01/13/2021

Chinese IPO Qilian Doubles in U.S. Trading Debut

Two Chinese initial public offerings opened for trading Tuesday, with Qilian International Holding Group making a powe...

02/24/2020

AnPac Bio-Medical Science Co., Ltd’s $16 Million Initial Public Offering

Cleary Gottlieb Steen & Hamilton LLP acted as counsel to the Company, and Sheppard Mullin Richter & Hampton LLP ...

11/15/2019

Chinese cancer diagnostics provider AnPac Bio-Medical Science sets terms for $22 million US IPO

AnPac Bio-Medical Science, a Chinese provider of multi-cancer screening tests, announced terms for its US IPO on Friday....

UNIVEST SECURITIES IN THE NEWS

01/30/2020

AnPac Bio Announces Pricing of Initial Public Offering

SAN JOSE, Calif., Jan. 30, 2020 /PRNewswire/ — Anpac Bio-Medical Science Co., Ltd.  (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has priced its initial public offering of 1,333,360 American depositary shares (“ADSs”) at […]

11/15/2019

Chinese cancer diagnostics provider AnPac Bio-Medical Science sets terms for $22 million US IPO

AnPac Bio-Medical Science, a Chinese provider of multi-cancer screening tests, announced terms for its US IPO on Friday. The Lishui, China-based company plans to raise $22 million by offering 1.7 million ADSs at a price range of $12 to $14. Insiders intend to purchase $2 million worth of shares in the offering. At the midpoint […]

10/31/2019

Univest Securities, LLC. Announces Closing of IPO for its Client Happiness Biotech Group Limited (NASDAQ: HAPP), Marking the Second Nasdaq IPO of Uinvest in 2019

New York, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Univest Securities, LLC, a FINRA and SIPC member full-service investment bank and securities broker-dealer firm, today announced the closing of previously announced the initial public offering (“IPO”) for its client Happiness Biotech Group Limited (“Happiness” or Nasdaq: HAPP), marking the second Nasdaq IPO underwritten as the lead-left underwriter and the sole book-runner by Uinvest in 2019. On a firm commitment basis, Univest sold, on behalf of Happiness, 2,000,000 shares of its ordinary shares at of $5.50 per share for a total of $11,000,000 in gross proceeds before fees and expenses. Happiness’s ordinary shares began trading on the Nasdaq Capital Market (“Nasdaq”) on Friday, October 25th, 2019 under the trading symbol “HAPP”.

10/31/2019

Univest Securities, LLC. Announces Closing of IPO for its Client Happiness Biotech Group Limited (NASDAQ: HAPP), Marking the Second Nasdaq IPO of Uinvest in 2019

New York, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Univest Securities, LLC, a FINRA and SIPC member full-service investment bank and securities broker-dealer firm, today announced the closing of previously announced the initial public offering (“IPO”) for its client Happiness Biotech Group Limited (“Happiness” or Nasdaq: HAPP), marking the second Nasdaq IPO underwritten as the lead-left underwriter and the sole book-runner by Uinvest in 2019. On a firm commitment basis, Univest sold, on behalf of Happiness, 2,000,000 shares of its ordinary shares at of $5.50 per share for a total of $11,000,000 in gross proceeds before fees and expenses. Happiness’s ordinary shares began trading on the Nasdaq Capital Market (“Nasdaq”) on Friday, October 25th, 2019 under the trading symbol “HAPP”.